285 related articles for article (PubMed ID: 12517798)
1. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
Arboleda MJ; Lyons JF; Kabbinavar FF; Bray MR; Snow BE; Ayala R; Danino M; Karlan BY; Slamon DJ
Cancer Res; 2003 Jan; 63(1):196-206. PubMed ID: 12517798
[TBL] [Abstract][Full Text] [Related]
2. Akt2: a role in breast cancer metastasis.
Chau NM; Ashcroft M
Breast Cancer Res; 2004; 6(1):55-7. PubMed ID: 14680486
[TBL] [Abstract][Full Text] [Related]
3. Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells.
Lau MT; So WK; Leung PC
Cancer Lett; 2012 Jul; 320(2):198-204. PubMed ID: 22388103
[TBL] [Abstract][Full Text] [Related]
4. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
Liu AX; Testa JR; Hamilton TC; Jove R; Nicosia SV; Cheng JQ
Cancer Res; 1998 Jul; 58(14):2973-7. PubMed ID: 9679957
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
[TBL] [Abstract][Full Text] [Related]
6. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
7. Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells.
Wang J; Wan W; Sun R; Liu Y; Sun X; Ma D; Zhang N
Cell Signal; 2008 Jun; 20(6):1025-34. PubMed ID: 18353613
[TBL] [Abstract][Full Text] [Related]
8. CD98 modulates integrin beta1 function in polarized epithelial cells.
Cai S; Bulus N; Fonseca-Siesser PM; Chen D; Hanks SK; Pozzi A; Zent R
J Cell Sci; 2005 Mar; 118(Pt 5):889-99. PubMed ID: 15713750
[TBL] [Abstract][Full Text] [Related]
9. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Page C; Lin HJ; Jin Y; Castle VP; Nunez G; Huang M; Lin J
Anticancer Res; 2000; 20(1A):407-16. PubMed ID: 10769688
[TBL] [Abstract][Full Text] [Related]
14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
15. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
[TBL] [Abstract][Full Text] [Related]
16. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
Fiucci G; Ravid D; Reich R; Liscovitch M
Oncogene; 2002 Apr; 21(15):2365-75. PubMed ID: 11948420
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
[TBL] [Abstract][Full Text] [Related]
20. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
Söderlund K; Pérez-Tenorio G; Stål O
Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
